Distribution of adoptively transferred porcine T-lymphoblasts tracked by 18F-2-fluoro-2-deoxy-d-glucose and position emission tomography

Nuclear Medicine and Biology

Volumn 38, Issue 6, 2011, Pages 827-833

  Eriksson, Olof ^a,b   Sadeghi, Arian ^a   Carlsson, Björn ^a   Eich, Torsten ^a   Lundgren, Torbjörn ^c   Nilsson, Bo ^a   Tötterman, Thomas ^a   Korsgren, Olle ^a   Sundin, Anders ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b BIACORE AB   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

18F FDG; Adoptive transfer; Cell trafficking; Positron emission tomography; T lymphoblasts

Indexed keywords

DEXTRAN SULFATE; FLUORODEOXYGLUCOSE F 18;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL KINETICS; CELL LABELING; CELL MIGRATION; CELL TRACKING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DISTRIBUTION; DRUG UPTAKE; FEASIBILITY STUDY; HEART; ISOTOPE LABELING; LIVER; LUNG; LYMPHOCYTE TRANSFUSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE STUDY; SPLEEN; T LYMPHOBLAST; TISSUE DISTRIBUTION;

ANIMALS; CELL SEPARATION; DEXTRAN SULFATE; FLUORODEOXYGLUCOSE F18; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE TRANSFUSION; MOLECULAR WEIGHT; POSITRON-EMISSION TOMOGRAPHY; SWINE; T-LYMPHOCYTES;

EID: 80051678177     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.02.011     Document Type: Article

References (17)

1. Rosenberg S.A., Restifo N.P., Yang J.C., Morgan R.A., Dudley M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008, 8(4):299-308.
2. Dudley M.E., Wunderlich J.R., Yang J.C., Sherry R.M., Topalian S.L., Restifo N.P., et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005, 23(10):2346-2357.
3. Ponomarev V. Nuclear imaging of cancer cell therapies. J Nucl Med 2009, 50(7):1013-1016. Epub 2009 Jun 12. Review.
4. Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J Nucl Med 1991, 32(4):623-648. discussion 649-50.
5. Osman S., Danpure H.J. The use of 2-[18F]fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Radiat Appl Instrum B 1992, 19(2):183-190.
6. Botti C., Negri D.R., Seregni E., Ramakrishna V., Arienti F., Maffioli L., et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med 1997, 24(5):497-504.
7. Adonai N., Nguyen K.N., Walsh J., Iyer M., Toyokuni T., Phelps M.E., et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A 2002, 99(5):3030-3035. Epub 2002 Feb 26.
8. Meier R., Piert M., Piontek G., Rudelius M., Oostendorp R.A., Senekowitsch-Schmidtke R., et al. Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors. Nucl Med Biol 2008, 35(5):579-588. Epub 2008 May 2.
9. Eich T., Eriksson O., Sundin A., Estrada S., Brandhorst D., Brandhorst H., et al. Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 2007, 84(7):893-898.
10. Eich T., Eriksson O., Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007, 356(26):2754-2755.
11. Eriksson O., Eich T., Sundin A., Tibell A., Tufveson G., Andersson H., et al. Positron emission tomography in clinical islet transplantation. Am J Transplant 2009, 9(12):2816-2824.
12. Dixon A.E., Mandac J.B., Martin P.J., Hackman R.C., Madtes D.K., Clark J.G. Adherence of adoptively transferred alloreactive Th1 cells in lung: partial dependence on LFA-1 and ICAM-1. Am J Physiol Lung Cell Mol Physiol 2000, 279(3):L583-L591.
13. Perez L.E., Alpdogan O., Shieh J.H., Wong D., Merzouk A., Salari H., et al. Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Exp Hematol 2004, 32(3):300-307.
14. Hayakawa J., Migita M., Ueda T., Fukazawa R., Adachi K., Ooue Y., et al. Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells. J Nippon Med Sch 2009, 76(4):198-208.
15. Koehne G., Doubrovin M., Doubrovina E., Zanzonico P., Gallardo H.F., Ivanova A., et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 2003, 21(4):405-413. Epub 2003 Mar 24.
16. Ponomarev V., Doubrovin M., Lyddane C., Beresten T., Balatoni J., Bornman W., et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 2001, 3(6):480-488.
17. Morgan R.A., Yang J.C., Kitano M., Dudley M.E., Laurencot C.M., Rosenberg S.A. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 2010, 18(4):843-851.